Hydrogel maker United-Guardian's Q2 sales rise on cosmetic ingredient demand
Hydrogel maker United-Guardian's Q2 sales rise on cosmetic ingredient demand
Overview
U.S. specialty ingredients maker's Q2 net sales rose 10% yr/yr, net income up 16%
Growth driven by increased cosmetic ingredient sales, mainly from Ashland Specialty Ingredients
Pharmaceutical sales rose 1% in Q2, with Renacidin as main growth driver
Outlook
United-Guardian says it is focused on expanding promotional efforts for Renacidin in 2026
Result Drivers
COSMETIC INGREDIENT SALES - Co said Q2 cosmetic ingredient sales rose 44%, mainly due to resumed regular purchasing by Ashland Specialty Ingredients after inventory reductions in 2025
PHARMACEUTICAL SALES - Q2 pharmaceutical sales rose 1%, with Renacidin cited as the primary growth driver
Company press release: ID:nGNX5XcFS6
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue |
| $3.10 mln |
|
Q2 EPS |
| $0.16 |
|
Reuters Recommended Reads
Aug 5 - e.l.f. Beauty beats Q1 revenue estimates on retail, e-commerce strength; lifts 2027 FY guidance
Aug 4 - Flavors and fragrances maker IFF's Q2 sales rise 2%, unveils $2.5 bln buyback
Aug 7 - Calumet Q2 sales beat estimates on demand for specialty products
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)